Showing results (1871-1880 of 1,979) with videos related to

Sort By:
Pageof 198
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Psychiatry|January 10, 2008
Five essential elements of immediate and mid-term mass trauma intervention: empirical evidenceStevan E Hobfoll, Patricia Watson, Carl C Bell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.
Maternal & Child Nutrition|July 19, 2012
The Alberta Pregnancy Outcomes and Nutrition (APrON) cohort study: rationale and methodsBonnie J Kaplan, Gerald F Giesbrecht, Brenda M Y Leung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, et al.
Breast Cancer Research : BCR|May 9, 2025
Circulating immune cells exhibit distinct traits linked to metastatic burden in breast cancerS Mangiola, R Brown, C Zhan, et al.
Plos Pathogens|March 6, 2020
Pathogen to commensal? Longitudinal within-host population dynamics, evolution, and adaptation during a chronic >16-year Burkholderia pseudomallei infectionTalima Pearson, Jason W Sahl, Crystal M Hepp, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 13, 2018
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter StudyCatherine C Bell, Anita C A Dankers, Volker M Lauschke, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 7, 2018
ECFS best practice guidelines: the 2018 revisionCarlo Castellani, Alistair J A Duff, Scott C Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199Mark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
Pageof 198